Your browser doesn't support javascript.
loading
Prior Authorization Requirements for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Across US Private and Public Payers.
Doshi, Jalpa A; Puckett, Justin T; Parmacek, Michael S; Rader, Daniel J.
Affiliation
  • Doshi JA; From the Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Dr Doshi, J.T. Puckett, Dr Parmacek, and Dr Rader) and the Leonard Davis Institute of Health Economics, Philadelphia (Dr Doshi). jdoshi@mail.med.upenn.edu.
  • Puckett JT; From the Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Dr Doshi, J.T. Puckett, Dr Parmacek, and Dr Rader) and the Leonard Davis Institute of Health Economics, Philadelphia (Dr Doshi).
  • Parmacek MS; From the Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Dr Doshi, J.T. Puckett, Dr Parmacek, and Dr Rader) and the Leonard Davis Institute of Health Economics, Philadelphia (Dr Doshi).
  • Rader DJ; From the Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Dr Doshi, J.T. Puckett, Dr Parmacek, and Dr Rader) and the Leonard Davis Institute of Health Economics, Philadelphia (Dr Doshi).
Circ Cardiovasc Qual Outcomes ; 11(1): e003939, 2018 01.
Article in En | MEDLINE | ID: mdl-29326146
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serine Proteinase Inhibitors / Private Sector / Eligibility Determination / Dyslipidemias / Prior Authorization / PCSK9 Inhibitors / Medical Assistance / Anticholesteremic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Circ Cardiovasc Qual Outcomes Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2018 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serine Proteinase Inhibitors / Private Sector / Eligibility Determination / Dyslipidemias / Prior Authorization / PCSK9 Inhibitors / Medical Assistance / Anticholesteremic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Circ Cardiovasc Qual Outcomes Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2018 Document type: Article Country of publication: United States